Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
About this study
This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC. The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?
- Condition
- NSCLC, Neoadjuvant Therapy
- Sponsor
- Qian Chu
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 4
- Minimum age: 18 years
- Study condition: NSCLC, Neoadjuvant Therapy
- pathologically diagnosed non-small cell lung cancer
- The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection
Exclusion 2
- recurrent or metastatic lung cancer;
- patients with other primary tumors
Where
2 sites, 2 recruiting
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
Tongji hospital
Wuhan, Hubei, China
Contact
-
Minghao Hu
8613396366466 huminghao2010@126.com
Potential match only. Final eligibility is determined by the study team.